← Leaderboards
Alison Evelynn Ondrus
University Of Illinois At Chicago
$1,097,133
Attributed
$1,097,133
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $550K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,097,133 · 2
By mechanism
R35$943,691 · 1
F32$153,442 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Alan Douglas Kinghorn$8,986,673
- Pavel A Petukhov$5,330,073
- Elizaveta V Benevolenskaya$3,795,509
- Brandon Nicolay$248,274
- You-Yang Zhao$24,398,532
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSignal TransductionSmall MoleculeNext GenerationProteinsReceptorOncogenicAutomobile DrivingAffectAdolescentBinding ProteinsBiochemicalBiochemical GeneticsBiologicalClinical ApplicationAnalogCollaborationsCellsCellular TargetingChemical SynthesisAdultChildChildhoodBase Sequence
Grant awards (5)
Molecular tools for cholesterol metabolite signaling$393,720
R35 · FY2025 · GM · contact PI
Molecular tools for cholesterol metabolite signaling$549,971
R35 · FY2024 · GM · contact PI
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers$36,498
F32 · FY2016 · CA · contact PI
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers$59,966
F32 · FY2015 · CA · contact PI
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers$56,978
F32 · FY2014 · CA · contact PI